» Articles » PMID: 18672620

Effect of Leukemia Inhibitory Factor (LIF) on the Quality of in Vitro Produced Mouse Blastocysts and Subsequent Derivation of Embryonic Stem (ES) Cells

Overview
Specialty General Medicine
Date 2008 Aug 5
PMID 18672620
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the effect of leukemia inhibitory factor (LIF) on the quality of in vitro produced mouse blastocyst and the efficiency of embryonic stem (ES) cell derivation.

Design: Experimental study

Setting: Reproductive Medicine Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University

Material And Method: In vivo fertilized zygotes were collected and subjected to in vitro culture in potassium simplex optimized medium (KSOM) containing 1,000 unit/ml LIF. The developmental ability of the zygote to blastocyst-stage and the cell numbers in blastocysts were evaluated Expanded blastocysts developed in different culture media were subsequently subjected to ES cell derivation. MAIN OUTCOME MEASURE (s): The influence of LIF on the quality of and the total cell numbers of blastocyst developed in vitro.

Results: Supplementation of LIF in KSOM increased the rate of hatching blastocysts (63.8% vs. 53.7%; p < 0.05) and total cell numbers (91.4 +/- 15.0 vs. 85.1 +/- 7.7; p < 0.05) compared to KSOM alone. ES cells were obtained 66.7% from blastocysts developed in KSOM-LIF versus 41.7% in KSOM (p > 0.05). Established ES cell lines showed typical colony and characteristics of pluripotent murine ES cells.

Conclusion: LIF improved the quality of in vitro produced blastocysts but not enhanced ES cell derivation.

Citing Articles

Leptin treatment of in vitro cultured embryos increases outgrowth rate of inner cell mass during embryonic stem cell derivation.

Taskin A, Kocabay A, Ebrahimi A, Karahuseyinoglu S, Sahin G, Ozcimen B In Vitro Cell Dev Biol Anim. 2019; 55(7):473-481.

PMID: 31214928 DOI: 10.1007/s11626-019-00367-y.


Optimization of protocols for derivation of mouse embryonic stem cell lines from refractory strains, including the non obese diabetic mouse.

Davies T, Fairchild P Stem Cells Dev. 2011; 21(10):1688-700.

PMID: 21933027 PMC: 3376457. DOI: 10.1089/scd.2011.0427.